From scientific innovation to commercial direction.

Identify partners whose capabilities fit your portfolio, commercial goals and target markets.

• Distributor evaluation and selection
• Hospital and clinic partnerships
• Government procurement channels
• Specialty centers for oncology and rare diseases

Prepare a coordinated tender approach, from identifying opportunities to aligning local partners.

• Tender identification and eligibility assessment
• Pricing strategy
• Documentation and submission support
• Partner alignment

Navigate country-specific requirements with a market-access approach tailored to your product and commercial priorities.

• Saudi Arabia: SFDA pathways
• UAE: Emirates Drug Establishment product regulation
• Bahrain: NHRA requirements
• Oman and Kuwait: Ministry of Health pathways
• Qatar: Ministry of Public Health pathways
• Pricing, reimbursement and market-access strategy

Shape your expansion strategy and identify the people needed to support local execution.

• Country managers
• Sales teams and medical representatives
• Market-access specialists
• Distributor leadership

Align specialized products with relevant partners, healthcare channels and market-entry priorities.

• Oncology portfolios
• Orphan drugs and rare-disease therapies
• High-value medical devices
• Advanced diagnostics